Physiologic significance of coronary collaterals in chronic total occlusions

Minh N Vo1, Emmanouil S Brilakis2, Malek Kass1

  • 1a University of Manitoba, Section of Cardiology, St. Boniface Hospital, 409 Tache Ave., Winnipeg, MB R2H 2A6, Canada.

Insights

Chronic total occlusions (CTOs) involve collateral vessels that protect against heart muscle death but not exercise-induced ischemia. This review examines collateral flow evidence and clinical significance in CTO patients, challenging outdated beliefs against revascularization.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Chronic total occlusions (CTOs) are prevalent in coronary artery disease patients.
  • Collateral vessels are present in most CTO patients, preventing myocardial necrosis but not ischemia during exertion.

Purpose of the Study:

  • To review the evidence for coronary collateral flow.
  • To assess the clinical significance of collateral flow in patients with CTOs.
  • To address misconceptions regarding collateral function and CTO revascularization.

Main Methods:

  • Literature review of studies on coronary collateral flow.
  • Analysis of research utilizing coronary pressure and flow velocity measurements.
  • Evaluation of the physiological significance of collateral circulation in CTOs.

Main Results:

  • Collateral vessels, while protective against necrosis, are insufficient to prevent exercise-induced myocardial ischemia.
  • Recent studies have advanced the understanding of coronary collateral physiology.
  • Evidence supports the clinical significance of collateral flow in CTO patients.

Conclusions:

  • The presence of well-developed collaterals does not negate the indication for CTO revascularization.
  • Increased knowledge of collateral physiology refutes the notion that patients are "protected" by collaterals.
  • CTO revascularization remains a critical consideration for improving outcomes in relevant patient populations.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
994
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
9.4K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
763
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
418
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
577
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
456